An Evaluation of the Economic Burden of Chronic Diseases in Nigeria

This study investigates the economic burden of chronic diseases in Nigeria, focusing on diabetes, cardiovascular diseases, and cancer. Using a quantitative approach, the analysis estimates direct and indirect costs, identifies contributing factors, and explores potential interventions. Findings reveal a substantial economic burden, with direct costs totaling $45 billion and indirect costs exceeding $100 billion annually. Healthcare utilization, disease prevalence, and lifestyle behaviors are significant drivers of costs. Policy interventions, including prevention programs, improved access to healthcare, and targeted interventions for vulnerable populations, are essential to mitigate the economic impact of chronic diseases in the developing world.